Dr. Paul T. Mehan, MD

Dr. Mehan practices at Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health.

Dr. Mehan's NPI, 1912115908, was assigned on May 21, 2007. Dr. Mehan graduated from Loyola University of Chicago, Stritch School of Medicine in 2006. Dr. Mehan holds Missouri license 2009013712.

Dr. Mehan's primary practice is Missouri Baptist Medical Center, at 3015 N Ballas Rd, Saint Louis, MO 63131 in St. Louis County. The practice phone is (314) 996-5000.

Dr. Mehan's primary practice is Missouri Baptist Medical Center in Saint Louis, Missouri, part of BJC Health. Dr. Mehan is also affiliated with Barnes-Jewish Hospital. The medical group on file is Missouri Baptist Medical Center. Dmand AI also links Dr. Mehan to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mehan practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mehan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mehan is licensed in Missouri.

CMS data shows 1,159 Medicare services from Dr. Mehan across 7 procedure codes in 2024, for 261 Medicare patients. Medicare paid $98,347 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 261 Medicare patients who saw Dr. Mehan in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mehan's median patient age at 75, with 35% women.

In 2024, Dr. Mehan wrote 1,069 Medicare Part D claims for 171 patients. 71% of them were for generic drugs. CMS names the drug for 933 of them, across 24 drugs with 11 or more claims each, at $2,907,606 in total drug cost. In 2023, CMS named 716 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Mehan for performance year 2024, reported individually. Dr. Mehan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Mehan, published from 2012 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms and Financial Stress. Dr. Mehan has published most often in JAMA Netw Open. Dr. Mehan's most frequent co-authors are Rajesh Bajaj, MD, Ruth C. Carlos, MD and Samir Mukundray Dalia, MD.

CMS Open Payments shows 44 general payments to Dr. Mehan from 21 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 92% of the total. Abbvie Inc. paid the most, $143.

Dr. Mehan graduated from Loyola University of Chicago, Stritch School of Medicine in 2006.